Descriptions

The autoinhibited protein was predicted that may have potential autoinhibitory elements via cis-regPred.

Autoinhibitory domains (AIDs)

Target domain

Relief mechanism

Assay

cis-regPred

Accessory elements

No accessory elements

Autoinhibited structure

Activated structure

1 structures for Q9BPV8

Entry ID Method Resolution Chain Position Source
AF-Q9BPV8-F1 Predicted AlphaFoldDB

298 variants for Q9BPV8

Variant ID(s) Position Change Description Diseaes Association Provenance
rs1577346050
CA354977991
2 T>P No ClinGen
Ensembl
CA2667741
rs775853815
3 A>V No ClinGen
ExAC
TOPMed
gnomAD
COSM4136990
rs139632884
CA2667739
4 A>T ovary [Cosmic] No ClinGen
cosmic curated
1000Genomes
ExAC
TOPMed
gnomAD
rs907526968
CA85721941
5 I>M No ClinGen
Ensembl
rs199907771
CA2667738
5 I>V No ClinGen
ESP
ExAC
TOPMed
gnomAD
rs1560035683
CA354977891
8 Q>H No ClinGen
Ensembl
rs770903652
CA354977881
10 E>* No ClinGen
ExAC
TOPMed
gnomAD
rs770903652
CA354977882
10 E>K No ClinGen
ExAC
TOPMed
gnomAD
rs770903652
CA2667737
10 E>Q No ClinGen
ExAC
TOPMed
gnomAD
rs949361307
CA85721933
12 S>N No ClinGen
Ensembl
CA354977852
rs1577345897
14 L>P No ClinGen
Ensembl
TCGA novel 15 P>Q Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
rs1451516284
CA354977842
16 K>* No ClinGen
TOPMed
gnomAD
rs1451516284
CA354977844
16 K>Q No ClinGen
TOPMed
gnomAD
CA354977839
rs1577345875
16 K>R No ClinGen
Ensembl
rs766350629
CA2667723
17 V>M No ClinGen
ExAC
TOPMed
gnomAD
rs1466243562
CA354977655
20 E>D No ClinGen
TOPMed
rs749980757
CA2667721
20 E>G No ClinGen
ExAC
gnomAD
CA2667722
rs749980757
20 E>V No ClinGen
ExAC
gnomAD
rs764745405
CA354977651
21 A>P No ClinGen
ExAC
gnomAD
rs764745405
CA2667720
21 A>T No ClinGen
ExAC
gnomAD
CA354977628
rs141361811
CA2667719
22 M>I No ClinGen
ESP
ExAC
TOPMed
gnomAD
rs776306831
CA2667718
23 N>T No ClinGen
ExAC
gnomAD
rs1360716223
CA354977581
26 V>A No ClinGen
gnomAD
CA354977583
rs1360716223
26 V>E No ClinGen
gnomAD
rs772423641
CA2667717
26 V>M No ClinGen
ExAC
TOPMed
gnomAD
CA2667716
rs759952511
27 M>I No ClinGen
ExAC
TOPMed
gnomAD
CA85721742
rs749193587
29 G>V No ClinGen
Ensembl
rs771476846
CA2667714
31 N>K No ClinGen
ExAC
gnomAD
CA2667715
rs774782565
31 N>S No ClinGen
ExAC
TOPMed
gnomAD
CA354977491
rs1464507733
32 R>T No ClinGen
gnomAD
CA354977457
rs1189050105
34 E>V No ClinGen
gnomAD
CA354977441
rs371578438
35 R>L No ClinGen
ESP
ExAC
TOPMed
gnomAD
COSM1536977
CA2667711
rs371578438
35 R>Q lung Variant assessed as Somatic; 0.0 impact. [Cosmic, NCI-TCGA] No ClinGen
cosmic curated
ESP
ExAC
NCI-TCGA
TOPMed
gnomAD
rs773366464
CA2667712
35 R>W No ClinGen
ExAC
TOPMed
gnomAD
CA354977440
rs1473210909
36 C>S No ClinGen
TOPMed
CA354977417
rs1158083512
37 P>R No ClinGen
TOPMed
CA2667710
rs146597143
38 R>G No ClinGen
ESP
ExAC
TOPMed
gnomAD
rs781282890
CA2667709
40 T>I No ClinGen
ExAC
gnomAD
CA354977372
rs1200037078
41 R>Q No ClinGen
TOPMed
gnomAD
rs754757932
CA2667708
41 R>W No ClinGen
ExAC
TOPMed
gnomAD
CA354977358
rs1405928932
42 I>R No ClinGen
TOPMed
CA2667707
rs746804027
43 V>A No ClinGen
ExAC
gnomAD
CA354977338
rs1257306724
44 Q>* No ClinGen
TOPMed
gnomAD
CA354977340
rs1257306724
44 Q>E No ClinGen
TOPMed
gnomAD
rs1233849357
CA354977311
46 V>L No ClinGen
gnomAD
rs867914537
CA85721672
47 F>L No ClinGen
Ensembl
CA2667706
rs779815610
50 L>V No ClinGen
ExAC
gnomAD
TCGA novel 51 Y>H Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
CA2667705
rs758381185
52 T>A No ClinGen
ExAC
gnomAD
rs1577344361
CA354977220
53 V>A No ClinGen
Ensembl
CA85721664
rs902661215
54 V>I No ClinGen
TOPMed
rs1055421055
CA85721663
55 F>S No ClinGen
TOPMed
CA85721660
rs868119745
58 G>D No ClinGen
Ensembl
rs936533736
CA85721662
58 G>S Variant assessed as Somatic; impact. [NCI-TCGA] No ClinGen
NCI-TCGA
gnomAD
rs372729106
CA85721658
59 I>T No ClinGen
Ensembl
rs756829710
CA2667702
66 L>V No ClinGen
ExAC
gnomAD
CA2667700
rs763750367
69 F>L No ClinGen
ExAC
gnomAD
CA2667699
rs759831858
70 V>I No ClinGen
ExAC
gnomAD
rs1277334026
CA354976986
72 I>M No ClinGen
TOPMed
rs774813657
CA2667697
72 I>V No ClinGen
ExAC
gnomAD
CA2667696
rs766749093
73 P>S No ClinGen
ExAC
gnomAD
TCGA novel 74 S>C Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
rs1577344194
CA354976925
77 T>I No ClinGen
Ensembl
rs1262461075
CA354976866
81 Y>* No ClinGen
TOPMed
rs748249195
CA2667692
81 Y>C No ClinGen
ExAC
gnomAD
TCGA novel 84 N>K Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
rs1214179778
CA354976819
85 T>I No ClinGen
gnomAD
rs1227578058
CA354976806
86 L>F No ClinGen
TOPMed
gnomAD
rs769029900
CA2667690
86 L>S No ClinGen
ExAC
gnomAD
CA85721595
rs967488878
88 A>S No ClinGen
Ensembl
rs746749067
CA2667689
88 A>V No ClinGen
ExAC
gnomAD
rs1376178770
CA354976776
89 D>A No ClinGen
gnomAD
CA354976771
rs1055009153
89 D>E No ClinGen
TOPMed
gnomAD
CA2667687
rs747246139
89 D>N No ClinGen
ExAC
TOPMed
gnomAD
CA2667685
rs778773836
91 I>V No ClinGen
ExAC
gnomAD
TCGA novel 94 L>I Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
CA2667684
rs756701413
95 M>I No ClinGen
ExAC
gnomAD
CA354976633
rs1382581297
99 K>N No ClinGen
gnomAD
TCGA novel 100 I>V Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
CA85721534
rs987493533
103 D>N No ClinGen
TOPMed
gnomAD
rs1379145180
CA354976516
109 W>* No ClinGen
gnomAD
CA354976511
rs1191323915
109 W>C No ClinGen
TOPMed
gnomAD
TCGA novel 112 R>K Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
rs144128158
CA2667680
113 A>D No ClinGen
1000Genomes
ESP
ExAC
TOPMed
gnomAD
rs144128158
CA354976463
113 A>V No ClinGen
1000Genomes
ESP
ExAC
TOPMed
gnomAD
CA354976458
rs1326423321
114 F>I No ClinGen
TOPMed
rs368981427
CA2667678
114 F>L No ClinGen
ESP
ExAC
TOPMed
gnomAD
CA354976432
rs1304227985
115 V>A No ClinGen
gnomAD
rs750882702
CA354976413
117 R>C No ClinGen
ExAC
TOPMed
gnomAD
rs542808259
CA2667676
117 R>H No ClinGen
ExAC
TOPMed
gnomAD
rs750882702
CA2667677
117 R>S No ClinGen
ExAC
TOPMed
gnomAD
rs184462683
CA2667674
118 F>L No ClinGen
1000Genomes
ExAC
TOPMed
gnomAD
CA354976380
rs1322681529
119 S>F No ClinGen
gnomAD
rs575804697
CA85721450
120 S>L Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] No ClinGen
NCI-TCGA
TOPMed
gnomAD
rs768905525
CA2667673
120 S>T No ClinGen
ExAC
gnomAD
rs1176114027
CA354976345
122 I>M No ClinGen
gnomAD
CA2667671
rs200152293
123 F>L No ClinGen
1000Genomes
ExAC
TOPMed
gnomAD
rs771887632
CA2667670
125 E>A No ClinGen
ExAC
gnomAD
CA2667669
rs745665642
125 E>D No ClinGen
ExAC
gnomAD
CA354976311
rs1268247393
127 M>I No ClinGen
TOPMed
CA354976313
rs1265053963
127 M>T No ClinGen
gnomAD
CA2667668
rs563913195
128 Y>D No ClinGen
ExAC
gnomAD
rs770889205
CA2667667
129 V>G No ClinGen
ExAC
TOPMed
CA354976294
rs1560034274
130 G>C No ClinGen
Ensembl
CA354976290
rs1378627478
131 I>V No ClinGen
TOPMed
CA354976279
rs1429932628
132 V>G No ClinGen
TOPMed
CA2667665
rs148391906
132 V>M No ClinGen
ESP
ExAC
TOPMed
gnomAD
rs144496684
CA2667663
135 G>R No ClinGen
ESP
ExAC
TOPMed
gnomAD
rs144496684
CA354976265
135 G>W No ClinGen
ESP
ExAC
TOPMed
gnomAD
rs1215665537
CA354976259
136 L>F No ClinGen
gnomAD
CA354976255
rs1363166676
137 I>L No ClinGen
TOPMed
CA354976249
rs1276671546
137 I>M No ClinGen
gnomAD
rs1399820673
CA354976247
138 A>T No ClinGen
gnomAD
CA354976243
rs1356533560
138 A>V No ClinGen
gnomAD
CA85721378
rs866620319
139 F>L No ClinGen
gnomAD
CA354976238
rs1159733246
139 F>S No ClinGen
gnomAD
rs974375450
CA354976219
142 F>L No ClinGen
TOPMed
gnomAD
CA2667662
rs200663977
142 F>L No ClinGen
ExAC
TOPMed
gnomAD
CA85721375
rs974375450
142 F>V No ClinGen
TOPMed
gnomAD
TCGA novel 144 K>N Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
CA2667661
rs758720888
144 K>R No ClinGen
ExAC
gnomAD
rs1032617700
CA85721374
145 I>S No ClinGen
TOPMed
CA2667659
rs578001925
146 I>M No ClinGen
ExAC
gnomAD
rs966937624
CA85721348
148 P>L No ClinGen
TOPMed
CA354976173
rs1256617458
149 L>F No ClinGen
gnomAD
rs138841969
CA2667657
149 L>S No ClinGen
1000Genomes
ESP
ExAC
TOPMed
gnomAD
TCGA novel 150 R>I Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
rs1054780321
CA85721321
151 N>S No ClinGen
TOPMed
rs1291180554
CA354976148
153 F>I No ClinGen
TOPMed
CA354976135
rs1482439582
155 K>* No ClinGen
gnomAD
rs936613622
CA85721307
156 K>N No ClinGen
TOPMed
gnomAD
rs368920684
CA2667655
156 K>Q No ClinGen
ESP
ExAC
TOPMed
gnomAD
rs147188000
CA354976123
157 P>A No ClinGen
ESP
ExAC
TOPMed
gnomAD
rs772189699
CA2667653
157 P>H No ClinGen
ExAC
rs147188000
CA2667654
157 P>T Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] No ClinGen
ESP
ExAC
NCI-TCGA
TOPMed
gnomAD
rs1560033985 157 P>T Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] No NCI-TCGA
CA85721282
rs199795727
158 V>F No ClinGen
gnomAD
rs199623818
CA2667652
162 T>M No ClinGen
ExAC
TOPMed
gnomAD
CA354976078
rs1218584463
164 S>* No ClinGen
gnomAD
CA354976076
rs1218584463
164 S>L No ClinGen
gnomAD
CA354976057
rs1315275961
167 I>N No ClinGen
gnomAD
CA354976056
rs1315275961
167 I>T No ClinGen
gnomAD
rs749197349
CA2667649
168 W>S No ClinGen
ExAC
rs1397410740
CA354976032
170 F>C No ClinGen
TOPMed
gnomAD
CA354976023
rs376836205
171 L>F No ClinGen
1000Genomes
ESP
ExAC
TOPMed
gnomAD
CA85721266
rs201802200
172 F>L No ClinGen
gnomAD
rs751271920
CA2667643
174 I>M No ClinGen
ExAC
gnomAD
CA2667645
rs780854560
174 I>N No ClinGen
ExAC
TOPMed
gnomAD
rs780854560
CA354976004
174 I>T No ClinGen
ExAC
TOPMed
gnomAD
rs945152607
CA85721261
174 I>V No ClinGen
Ensembl
rs779389899
CA354976003
175 S>A No ClinGen
ExAC
TOPMed
gnomAD
rs779389899
CA2667642
175 S>P No ClinGen
ExAC
TOPMed
gnomAD
rs1322373814
CA354975986
178 N>D No ClinGen
TOPMed
CA2667640
rs754383910
179 T>A No ClinGen
ExAC
TOPMed
gnomAD
VAR_028299
CA2667639
rs1466684
179 T>M No ClinGen
UniProt
1000Genomes
ESP
ExAC
TOPMed
dbSNP
gnomAD
rs752753008
CA85721202
180 I>F No ClinGen
ExAC
gnomAD
rs767732637
CA2667636
180 I>N No ClinGen
ExAC
TOPMed
gnomAD
CA85721193
rs767732637
180 I>T No ClinGen
ExAC
TOPMed
gnomAD
CA2667637
rs752753008
180 I>V No ClinGen
ExAC
gnomAD
CA2667634
rs774600360
182 S>N No ClinGen
ExAC
gnomAD
rs766160966
CA2667633
183 N>D No ClinGen
ExAC
gnomAD
rs954752105
CA85721177
183 N>K No ClinGen
Ensembl
rs1320101430
CA354975938
185 E>D No ClinGen
TOPMed
CA2667632
rs762746331
188 P>L No ClinGen
ExAC
gnomAD
rs1243122579
COSM1593379
CA354975924
188 P>S Variant assessed as Somatic; 0.0 impact. endometrium [NCI-TCGA, Cosmic] No ClinGen
cosmic curated
NCI-TCGA
gnomAD
CA2667629
rs760204895
189 S>L No ClinGen
ExAC
TOPMed
gnomAD
CA2667630
rs769647505
189 S>T No ClinGen
ExAC
gnomAD
CA2667628
rs775981509
190 S>C No ClinGen
ExAC
gnomAD
rs974761001
CA85721160
190 S>T No ClinGen
gnomAD
CA2667627
rs188633801
194 C>F No ClinGen
1000Genomes
ExAC
gnomAD
rs1295034775
CA354975887
194 C>G No ClinGen
gnomAD
rs188633801
CA2667626
194 C>S No ClinGen
1000Genomes
ExAC
gnomAD
CA354975880
rs1159411334
195 A>V No ClinGen
gnomAD
rs1250338520
CA354975861
198 K>T No ClinGen
TOPMed
CA354975846
rs1560033565
200 P>L Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] No ClinGen
Ensembl
NCI-TCGA
CA85721151
rs963633242
200 P>S No ClinGen
Ensembl
rs921654890
CA85721150
202 G>E No ClinGen
TOPMed
gnomAD
CA354975836
rs921654890
COSM1179872
202 G>V prostate [Cosmic] No ClinGen
cosmic curated
TOPMed
gnomAD
CA2667625
rs779910558
204 K>T No ClinGen
ExAC
gnomAD
rs757639633
CA2667624
205 W>* No ClinGen
ExAC
TOPMed
gnomAD
rs1016469526
CA85721141
205 W>C No ClinGen
Ensembl
CA354975797
rs1425121179
208 M>T No ClinGen
TOPMed
CA2667623
rs149544268
208 M>V No ClinGen
1000Genomes
ESP
ExAC
TOPMed
gnomAD
CA354975766
rs1164933189
212 I>T No ClinGen
TOPMed
CA2667622
rs756603051
213 C>R No ClinGen
ExAC
gnomAD
CA2667621
rs756603051
213 C>S No ClinGen
ExAC
gnomAD
rs1362703932
CA354975761
213 C>Y No ClinGen
TOPMed
CA354975728
COSM1133678
rs1287201043
217 F>L urinary_tract [Cosmic] No ClinGen
cosmic curated
gnomAD
rs1455611709
CA354975715
219 T>A No ClinGen
TOPMed
rs1161254625
CA354975713
219 T>I No ClinGen
TOPMed
TCGA novel 219 T>P Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
rs1355485131
CA354975708
220 V>A No ClinGen
gnomAD
CA2667620
rs753299486
220 V>F No ClinGen
ExAC
gnomAD
CA2667617
rs755157659
225 L>F No ClinGen
ExAC
gnomAD
TCGA novel 225 L>R Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
CA2667616
rs751770650
226 V>A No ClinGen
ExAC
gnomAD
rs531618516
COSM1419955
CA85721093
227 F>L large_intestine [Cosmic] No ClinGen
cosmic curated
gnomAD
COSM1419955
CA2667614
rs150366287
227 F>L Variant assessed as Somatic; 0.0 impact. large_intestine [NCI-TCGA, Cosmic] No ClinGen
cosmic curated
ESP
ExAC
NCI-TCGA
TOPMed
gnomAD
CA354975632
rs1421738088
231 I>T No ClinGen
gnomAD
rs200013625
CA85721082
231 I>V No ClinGen
1000Genomes
rs1358917802
CA354975624
232 A>P No ClinGen
gnomAD
CA354975616
rs1158305647
232 A>V No ClinGen
gnomAD
rs200963598
CA85721071
233 K>E No ClinGen
1000Genomes
TCGA novel 233 K>N Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
rs773010566
CA2667613
233 K>T No ClinGen
ExAC
TOPMed
gnomAD
rs765128279
CA354975585
234 K>N No ClinGen
ExAC
TOPMed
gnomAD
CA354975579
rs1328540438
235 V>L No ClinGen
TOPMed
rs771457469 235 V>S Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] No NCI-TCGA
rs771457469 235 V>Y Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
CA85721046
rs767264751
236 Y>* No ClinGen
gnomAD
CA85721051
rs201673223
236 Y>C Variant assessed as Somatic; impact. [NCI-TCGA] No ClinGen
1000Genomes
NCI-TCGA
TCGA novel 237 D>Y Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
rs569431405
CA2667610
239 Y>H No ClinGen
1000Genomes
ExAC
gnomAD
TCGA novel 240 R>I Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
CA354975510
rs1319744181
240 R>T No ClinGen
TOPMed
gnomAD
rs775216984
CA2667606
241 K>N No ClinGen
ExAC
gnomAD
rs746532106
CA2667607
241 K>Q No ClinGen
ExAC
gnomAD
CA85721028
rs746195218
242 S>C No ClinGen
ExAC
gnomAD
rs746195218
CA2667605
242 S>F No ClinGen
ExAC
gnomAD
rs749622675
CA2667604
244 S>R No ClinGen
ExAC
gnomAD
CA2667603
rs777980296
245 K>R No ClinGen
ExAC
TOPMed
gnomAD
rs756545023
CA2667602
247 R>K No ClinGen
ExAC
gnomAD
CA2667600
rs748602377
249 N>K No ClinGen
ExAC
CA354975337
rs1577342154
249 N>S No ClinGen
Ensembl
rs561301002
CA85721016
252 K>E No ClinGen
Ensembl
rs1471337877
CA354975258
253 L>M No ClinGen
TOPMed
TCGA novel 254 E>K Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
CA354975247
rs1160689762
254 E>Q No ClinGen
TOPMed
rs759096971
CA85721011
256 K>E No ClinGen
TOPMed
CA354975187
rs1469177413
257 V>E No ClinGen
TOPMed
TCGA novel 257 V>L Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
CA85721004
rs1000530433
258 F>S No ClinGen
Ensembl
rs754980456
CA2667598
259 V>A Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] No ClinGen
ExAC
NCI-TCGA
TOPMed
gnomAD
CA354975114
rs1404438401
261 V>A No ClinGen
gnomAD
CA2667595
rs377720689
261 V>M No ClinGen
1000Genomes
ESP
ExAC
TOPMed
gnomAD
TCGA novel 261 V>missing Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
rs1170956423
CA354975104
262 A>T No ClinGen
gnomAD
CA354975094
rs1469720704
262 A>V No ClinGen
gnomAD
TCGA novel 262 A>V Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
rs1577341951
CA354975082
263 V>G No ClinGen
Ensembl
CA354975028
rs1196503068
266 V>A No ClinGen
TOPMed
gnomAD
rs200030247
CA85720982
266 V>L Variant assessed as Somatic; impact. [NCI-TCGA] No ClinGen
Ensembl
NCI-TCGA
rs1477016523
CA354975025
267 C>R No ClinGen
gnomAD
TCGA novel 268 F>L Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
CA354975002
rs1455021157
270 P>S No ClinGen
TOPMed
gnomAD
rs945204880
CA85720971
276 V>A No ClinGen
TOPMed
gnomAD
CA2667594
rs750682032
276 V>F No ClinGen
ExAC
gnomAD
CA85720964
rs890940981
278 Y>H No ClinGen
Ensembl
CA2667593
rs764935400
279 T>I No ClinGen
ExAC
TOPMed
gnomAD
TCGA novel 283 T>N Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
rs376103971
CA85720931
285 N>S No ClinGen
ESP
TOPMed
gnomAD
rs61736003
CA2667590
290 R>G No ClinGen
1000Genomes
ESP
ExAC
TOPMed
gnomAD
rs975190098
CA85720923
291 L>R No ClinGen
Ensembl
CA354974857
rs1220622082
291 L>V No ClinGen
Ensembl
rs760223474
CA354974813
297 I>N No ClinGen
ExAC
TOPMed
rs760223474
CA2667588
297 I>T No ClinGen
ExAC
TOPMed
rs148292157
CA2667587
298 A>T No ClinGen
ESP
ExAC
TOPMed
gnomAD
CA2667586
rs771759173
298 A>V No ClinGen
ExAC
gnomAD
rs1269448762
CA354974799
300 E>K No ClinGen
gnomAD
CA2667585
rs759235588
302 T>I No ClinGen
ExAC
gnomAD
TCGA novel 306 A>Q Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
rs1332241263
CA354974748
307 A>V No ClinGen
gnomAD
rs1183735382
CA354974743
308 T>I No ClinGen
TOPMed
rs770045022
CA2667582
310 I>T No ClinGen
ExAC
TOPMed
gnomAD
CA85720856
rs1025591839
311 C>Y No ClinGen
TOPMed
TCGA novel 312 M>I Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
CA2667579
rs769169595
313 D>E No ClinGen
ExAC
gnomAD
rs781507151
CA2667580
313 D>V No ClinGen
ExAC
gnomAD
CA2667578
rs747561399
314 P>S No ClinGen
ExAC
rs780075715
CA2667577
318 I>T No ClinGen
ExAC
gnomAD
rs1419242485
CA354974677
318 I>V No ClinGen
gnomAD
rs369934525
CA2667576
COSM1593380
319 F>L endometrium [Cosmic] No ClinGen
cosmic curated
ESP
ExAC
TOPMed
gnomAD
CA85720816
rs992331106
319 F>S No ClinGen
Ensembl
CA2667574
rs376418702
324 F>I No ClinGen
ESP
TOPMed
gnomAD
rs750596329
CA2667573
324 F>Y No ClinGen
ExAC
gnomAD
rs779208733
CA2667572
326 E>A No ClinGen
ExAC
gnomAD
CA354974511
rs371851954
327 K>N No ClinGen
ESP
ExAC
TOPMed
gnomAD
CA2667569
rs200097493
330 C>R No ClinGen
1000Genomes
ExAC
TOPMed
gnomAD
rs1272000631
CA354974463
330 C>W No ClinGen
gnomAD
rs201083333
CA2667568
331 M>T No ClinGen
ESP
ExAC
TOPMed
gnomAD
CA2667567
rs752724201
332 Q>H No ClinGen
ExAC
TOPMed
gnomAD
CA2667566
rs767135062
335 K>R No ClinGen
ExAC
gnomAD
rs759179323
CA2667565
337 T>A No ClinGen
ExAC
TOPMed
gnomAD
rs1377652232
CA354974344
337 T>K No ClinGen
TOPMed
gnomAD
rs1445195988
CA354974332
338 A>E No ClinGen
gnomAD
CA2667564
rs145063671
338 A>S No ClinGen
ESP
ExAC
TOPMed
gnomAD
rs770644573
CA2667563
339 S>P No ClinGen
ExAC
gnomAD
rs777028773
CA2667561
342 E>Q No ClinGen
ExAC
gnomAD
CA354974248
rs1412096125
343 N>S No ClinGen
gnomAD
CA354974219
rs769046736
344 H>Q No ClinGen
ExAC
gnomAD
CA2667559
rs747508218
345 S>N No ClinGen
ExAC
gnomAD
CA2667558
rs780595250
346 S>I No ClinGen
ExAC
gnomAD
rs1445262301
CA354974136
350 N>T No ClinGen
TOPMed
gnomAD
CA354974106
rs1232197525
352 T>P No ClinGen
TOPMed
gnomAD
rs772080675
CA2667555
354 G>S No ClinGen
ExAC
gnomAD
CA354974048
rs1435886411
355 G>L No ClinGen
gnomAD
CA2667553
rs778963652
355 G>R No ClinGen
ExAC
TOPMed
gnomAD

No associated diseases with Q9BPV8

5 regional properties for Q9BPV8

Type Name Position InterPro Accession
domain Glutaredoxin 72 - 135 IPR002109
domain Glutaredoxin, eukaryotic/virial 72 - 153 IPR011899
domain Glutaredoxin subgroup 72 - 90 IPR014025-1
domain Glutaredoxin subgroup 118 - 131 IPR014025-2
domain Glutaredoxin subgroup 132 - 145 IPR014025-3

Functions

Description
EC Number
Subcellular Localization
  • Cell membrane; Multi-pass membrane protein
PANTHER Family
PANTHER Subfamily
PANTHER Protein Class
PANTHER Pathway Category No pathway information available

3 GO annotations of cellular component

Name Definition
endoplasmic reticulum The irregular network of unit membranes, visible only by electron microscopy, that occurs in the cytoplasm of many eukaryotic cells. The membranes form a complex meshwork of tubular channels, which are often expanded into slitlike cavities called cisternae. The ER takes two forms, rough (or granular), with ribosomes adhering to the outer surface, and smooth (with no ribosomes attached).
integral component of membrane The component of a membrane consisting of the gene products and protein complexes having at least some part of their peptide sequence embedded in the hydrophobic region of the membrane.
plasma membrane The membrane surrounding a cell that separates the cell from its external environment. It consists of a phospholipid bilayer and associated proteins.

1 GO annotations of molecular function

Name Definition
G protein-coupled purinergic nucleotide receptor activity Combining with a purine nucleotide and transmitting the signal across the membrane by activating an associated G-protein; promotes the exchange of GDP for GTP on the alpha subunit of a heterotrimeric G-protein complex.

3 GO annotations of biological process

Name Definition
cellular response to organic cyclic compound Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of an organic cyclic compound stimulus.
G protein-coupled receptor signaling pathway The series of molecular signals initiated by a ligand binding to its receptor, in which the activated receptor promotes the exchange of GDP for GTP on the alpha-subunit of an associated heterotrimeric G-protein complex. The GTP-bound activated alpha-G-protein then dissociates from the beta- and gamma-subunits to further transmit the signal within the cell. The pathway begins with receptor-ligand interaction, and ends with regulation of a downstream cellular process. The pathway can start from the plasma membrane, Golgi or nuclear membrane.
negative regulation of adenylate cyclase activity Any process that stops, prevents, or reduces the frequency, rate or extent of adenylate cyclase activity.

6 homologous proteins in AiPD

UniProt AC Gene Name Protein Name Species Evidence Code
Q9H244 P2RY12 P2Y purinoceptor 12 Homo sapiens (Human) PR
Q9UPC5 GPR34 Probable G-protein coupled receptor 34 Homo sapiens (Human) PR
Q9CPV9 P2ry12 P2Y purinoceptor 12 Mus musculus (Mouse) PR
Q9D8I2 P2yr13 P2Y purinoceptor 13 Mus musculus (Mouse) PR
Q9EPX4 P2ry12 P2Y purinoceptor 12 Rattus norvegicus (Rat) PR
Q6GUG4 P2ry13 P2Y purinoceptor 13 Rattus norvegicus (Rat) PR
10 20 30 40 50 60
MTAAIRRQRE LSILPKVTLE AMNTTVMQGF NRSERCPRDT RIVQLVFPAL YTVVFLTGIL
70 80 90 100 110 120
LNTLALWVFV HIPSSSTFII YLKNTLVADL IMTLMLPFKI LSDSHLAPWQ LRAFVCRFSS
130 140 150 160 170 180
VIFYETMYVG IVLLGLIAFD RFLKIIRPLR NIFLKKPVFA KTVSIFIWFF LFFISLPNTI
190 200 210 220 230 240
LSNKEATPSS VKKCASLKGP LGLKWHQMVN NICQFIFWTV FILMLVFYVV IAKKVYDSYR
250 260 270 280 290 300
KSKSKDRKNN KKLEGKVFVV VAVFFVCFAP FHFARVPYTH SQTNNKTDCR LQNQLFIAKE
310 320 330 340 350
TTLFLAATNI CMDPLIYIFL CKKFTEKLPC MQGRKTTASS QENHSSQTDN ITLG